Aiming to maintain a growth rate of around 18-22 per cent, FMCG firm GlaxoSmithKline will this year introduce around 10-12 products, including some from the international portfolio of its parent company.     

"We want to create a balanced product portfolio and for that the company is constantly expanding its offering. In the current year, we may introduce around 10-12 more products in India," GlaxoSmithKline Consumer Healthcare Executive Vice- President (Marketing) Shubhajit Sen told PTI.     

Click here for Cloud Computing

Also Read   Related Stories News Now - Horlicks aims Rs 50 cr sales from biscuits segment - Red flag for the runs - Dr Reddy's takes an earnings hit, terms it as a one-off event - GSK Consumer to focus on health food drinks - Cavin Kare eyeing more overseas markets - Denial of patent to Gilead beneficial for Indian firms

Also Read   Related Stories News Now - Wall Street up on Greece, but gains seen limited - FII-TO-FII: Pantaloon traded at 7% premium - Civic polls: Saffron alliance retains Mumbai, Thane - MCX awaits trading rules in commodity options, indices - Govt to provide incentives for electronic chip manufacturing More

On the launches from the GSK international's product portfolio, Sen said the company is currently test marketing a new product Breath Easy in India.     

He said, "We have started carrying out test marketing for the product in South and hopefully we will be launching it this year."     

The company had a sales of Rs 1,592 crore last year, of which around Rs 1,200 crore came from Horlicks.     

Sen said the company is working on enhancing the nutrient level of its existing products besides focusing on penetrating deeper into the market.     

"Our focus for this year will be on the health category. We are planning to increase the micronutrient elements of our existing products besides introducing some new categories," he said.

Sen said the company is focusing on increasing presence in the rural markets, which contribute around 30-35 per cent of the overall turnover.     

"We will keep increasing penetration across the country. Though south and east Indian markets have been doing well, we still feel there's lot of scope for growth in the smaller towns there," he said.      

He, however, did not reveal how much the company is planning to spend on various activities lined up this year but said the company earmarks around 12-13 per cent of its sales on marketing and promotional campaigns.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Wall Street up on Greece, but gains seen limited - FII-TO-FII: Pantaloon traded at 7% premium - Civic polls: Saffron alliance retains Mumbai, Thane - MCX awaits trading rules in commodity options, indices - Govt to provide incentives for electronic chip manufacturing

Tags : GlaxoSmithKline | FMCG industry | Horlicks | Consumer healthcare   Read Business news in  Advertisements -  Now property search gets more exciting than ever before! -  High Growth Business Opportunities in Africa - Register to explore -  Medium-sized businesses are the engines of a smarter planet. -  Save over Rs.3000 with IndianOil Citibank Card -  India's No. 1 Property Site. Click here to know more.. -  Get 5% cashback on telephone bills with Citi -  Diseases earlier, Saving Costs, Extending Lives. Know More.. -  Enjoy the journey as much as the destination. click to know more.. -  Exim Bank Conclave on India - Africa Project Partnership. Know more.. -  Creating Wealth made simple the SIP way. Know more.. -  Only Developer to give a guarantee on time space & rate. -  Office 365 for professionals and small businesses. -  Buy Your Property with Our Triple Guarantee in India. -  Improve Patient Care & Experience. Click here to know more -  Win a Business Class Ticket to Europe..Know more.. -   Introduce a New Automotive Luxury Car.. know more